 this study may provide prognostic markers for this disease. We have refined methods for flow cytometric monitoring of patient specimens for apoptosis induced by chemotherapy and have been able to detect apoptosis in specific cell populations. This has allowed us to demonstrate different sensitivities of specific cell lineages to chemotherapeutic agents. We have initiated a study of clonal
this study may provide prognostic markers for this disease. We get refine methods for flow cytometric monitoring of patient specimens for apoptosis induce by chemotherapy and have been able to detect apoptosis in specific cell populations. This has leave us to demonstrate different sensitivity of specific cell lineages to chemotherapeutic agent. We have initiated a study of clonal
 thls study may provide pronnostic markers yir thiv disezse. We hxve refined methods for flow cttomeugic monitoring of patkent specpmens for apoktosis induced by chemothcxapy zkd hare been able to cetect apo[tosis in spechfkc cell populations. This has allowed ts to drmlnstrate diffetent xqnsifpvlties of specific cell lineages fo chemmtherapeutic sgents. We have initiated a stufy of clonal
this study may provide prognostic markers for We refined methods flow cytometric monitoring induced chemotherapy and have able to detect in specific cell populations. This has us to demonstrate different sensitivities of specific cell lineages to chemotherapeutic agents. We initiated a study of clonal
 this study may provide prognoStic markerS for tHis DisEaSe. We Have Refined methods FOr flOw cytometric monitoring Of patIeNT speCImEns foR apoptoSIs INDucEd By CheMoTHeRapy aNd hAve been Able to deteCt aPoPtosis in specIFiC cell populAtiOns. This has alLowEd us to DeMonSTrate DifFerenT sensiTIvitieS of specifIc CEll linEAges to cHEMoTherApeutic agents. We haVE iNItiated a study oF clonaL
 this study may provide pr ognostic m arker s f orth is d isea se. We have re f ined  methods for flow cyto metri cm onit o ri ng of  patien t  s p e cim en sfor  a p op tosis  in duced b y chemothe rap yand have bee n  a ble to det ect  apoptosis i n s pecifi ccel l  popu lat ions.  Thish as all owed us t od emonst r ate dif f e re nt s ensitivities of s p ec i fic cell linea ges to  c h em o t her ape utic agent s.  We h a ve init i at e d a s t udy of clonal 
 this_study may_provide prognostic markers for_this disease._We_have refined_methods_for flow cytometric_monitoring of patient_specimens for apoptosis induced_by chemotherapy and_have_been able to detect apoptosis in specific cell populations. This has allowed us to_demonstrate_different sensitivities_of_specific_cell lineages to chemotherapeutic agents._We have initiated a study_of clonal